RVAC Medicines, a CBC-incubated mRNA platform company, raises US$140 million to expand R&D and manufacturing capacity
Summary
RVAC Medicines, a CBC-incubated mRNA platform company, raises US$140 million to expand R&D and manufacturing capacity
Funding
Amount
$140.0M
Total raised
Date
April 26, 2022
Announcement date
Investors
EDBI, CBC Group, CBC
Lead investors
Company
https://www.rvacmed.com/
Funded company
Classifications
industries
No industries detected
applications
Business Intelligence
AskAI Classifications
Labels
No AI classifications detected